UK pharma, Pfizer, has received gross proceeds of approximately £2.5bn (US$3.3bn) from the sale of its entire remaining shareholding in British healthcare company, Haleon, of approximately 662 million ordinary shares, representing…
UK: Pfizer raises £2.5bn from disposal of last holding in Haleon
…
…






